WORK Medical Technology Establishes U.S. Subsidiary, Work Bio Technologies, To Foster Global Expansion And Long-Term Growth
Why Is WORK Medical Technology Stock Falling Friday?
Why Is WORK Medical Technology Stock Falling On Wednesday?
WORK Medical Technology Group Is Trending Overnight — Here's Why WOK Stock Surged Over 69% In After-Hours Session
AI Healthcare and BioToken Partnership Expands WORK Medical’s (WOK) Digital Asset Ambitions
WORK Medical Collaborates with Novabioplus to Unlock Biological Data Value with AI, Advancing the “BioToken” Assetization Model
WORK Medical Technology Inks Agreement With Shanghai Novabioplus Biotechnology Over Joint Development Of Intelligent Medical Models
WORK Medical Deepens Web3.0 Strategic Layout: Co-authors Asset Tokenization Whitepaper
WORK Medical Grants East China Exclusive Distribution Rights for AI-Automated Blood Cell Morphology Analyzer, Sets RMB10 Million Sales Target for 2026
WORK Medical Technology Group LTD Subsidiary Obtains Manufacturing Approval for Its AI-Automated Blood Cell Morphology Analyzer
What's Going On With WORK Medical Technology Group Stock Today?
WORK Medical Technology Group shares are trading higher after the company announced its subsidiary, Hunan Saitumofei received manufacturing approval from the Hunan Provincial Medical Products Administration for its Class II medical device, the Artificial Intelligence-Automated Human Blood Cell Morphology Analyzer.
WORK Medical Technology Receives Hunan Provincial Medical Products Administration's Approval For Class II Medical Device
Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times
Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending
WORK Medical Technology Group LTD Announces 1-for-100 Reverse Stock Split Effective December 29, 2025
WORK Medical Announces 1-For-100 Reverse Stock Split, Effective December 29, 2025
WORK Medical Technology Group LTD Shares Halted On Circuit Breaker To The Downside, Stock Now Down -90.48%
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.